| Literature DB >> 29718981 |
Ying Zhang1,2,3, Pengxiang Qu1,2,3, Xiaonan Ma1,2,3, Fang Qiao1,2,3, Yefei Ma4, Suzhu Qing1,2,3, Yong Zhang1,2,3, Yongsheng Wang1,2,3, Wei Cui5,6.
Abstract
Serum starvation is a routine protocol for synchronizing nuclear donor cells to G0/G1 phase during somatic cell nuclear transfer (SCNT). However, abrupt serum deprivation can cause serious stress to the cells cultured in vitro, which might result in endoplasmic reticulum (ER) stress, chromosome damage, and finally reduce the success rate of SCNT. In the present study, the effects of tauroursodeoxycholic acid (TUDCA), an effective ER stress-relieving drug, on the nuclear donor cells under serum deprivation condition as well as following SCNT procedures were first assessed in the bovine. The results showed that TUDCA significantly reduced ER stress and cell apoptosis in those nuclear donor cells. Moreover, it significantly decreased the expression of Hdac1 and Dnmt1, and increased the level of H3K9 acetylation in nuclear donor cells compared with control group. SCNT reconstructed embryos cloned from TUDCA-treated donor cells showed significantly higher fusion, cleavage, blastocyst formation rate, total cell number in day 7 blastocysts, and lower apoptotic index than that from control group. In addition, the expression of Hdac1, Dnmt1 and Bax was significantly lower in blastocysts derived from TUDCA-treated donor cells than that from control group. In conclusion, TUDCA significantly reduced the ER stress of nuclear donor cells under serum starvation condition, and significantly improved the developmental competence of following SCNT reconstructed embryos when these TUDCA-treated cells were used as the nuclear donors.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29718981 PMCID: PMC5931650 DOI: 10.1371/journal.pone.0196785
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primers for q-PCR.
| Gene | Sequence | Product Size (bp) | Tm(°C) | Gene bank accession No. |
|---|---|---|---|---|
| 255 | 60 | AY141970 | ||
| 144 | 60 | BF076713 | ||
| 167 | 60 | NM_001075148.1 | ||
| 218 | 60 | NM_001078163.1 | ||
| 170 | 60 | XM_001789477.1 | ||
| 246 | 60 | NM_173894.1 | ||
| 137 | 60 | NM_001166486.1 | ||
| 168 | 60 | BT030718.1 | ||
| 138 | 60 | NM_182651.2 | ||
F: forward primer; R: reverse primer.
Fig 1Relative expression levels of endoplasmic reticulum (ER) stress related genes in donor fibroblast cells cultured in medium containing 10% FBS (normal condition) or 0.5% FBS (serum starvation condition) with TUDCA at different concentrations (0, 50, 100, 150 and 200 μM).
a-e: different letters indicate significant difference (P<0.05).
Fig 2Relative abundance of apoptosis-related genes (anti-apoptosis marker Bcl-2, pro-apoptosis marker Bax) and reprogramming-related genes (Hdac1 and Dnmt1) in control and TUDCA-treated donor cells.
a,b: different letters indicate significant difference (P<0.05).
Percentages of fibroblasts at different cell cycle phases under control and TUDCA treatment conditions.
| Group | Percentages of fibroblasts at different cell cycle phases (%) | ||
|---|---|---|---|
| G0/G1 | S | G2/M | |
| Control | 95.65±2.91 | 2.37±1.21 | 1.98±1.76 |
| TUDCA | 95.95±2.65 | 1.58±1.54 | 2.47±1.64 |
No significant difference between Control and TUDCA treatment groups (P>0.05).
Apoptosis analysis of donor cells in control and TUDCA treatment groups.
| Group | Annexin-negative | Apoptosis | Necrosis | Late apoptosis |
|---|---|---|---|---|
| Control | 90.2±1.3 | 5.4±0.4 | 1.0±0.3 | 3.4±1.0 |
| TUDCA | 95.9±0.9 | 1.1±0.2 | 1.5±0.5 | 1.5±0.7 |
Apoptosis was detected by annexin V/propidium iodide (PI) staining assay. Annexin-negative: cells without any annexin or PI signal; Apoptosis: cells with annexin signal only; Necrosis: cells with PI signal only; Late apoptosis/necrosis: cells with annexin and PI signals.
a,b: different superscripts within same column indicate significant difference (P<0.05).
Fig 3Global level of H3K9 acetylation in control and TUDCA-treated donor cells.
(A) H3K9 acetylation was stained as green, nuclei were counterstained with DAPI to visualize as blue. Scale bar: 20 μm. (B) Quantification of H3K9 acetylation/DNA signal intensities. a,b: different letters indicate significant difference (P<0.05).
Development of SCNT reconstructed embryos when control or TUDCA-treated cells were used as the nuclear donors.
| Groups | No. reconstructed oocytes | No. fused (%) | No. cleavage (%) | No. blastocyst (%) | Blastocyst cell number | Apoptotic index |
|---|---|---|---|---|---|---|
| Control | 270 | 186 (68.9) | 161 (86.6) | 55 (29.6) | 93.9±1.3 | 7.6±0.8 |
| TUDCA | 274 | 235 (85.8) | 219 (93.2) | 89 (37.9) | 107.5±2.2 | 2.2±0.7 |
a,b: different superscripts within same column indicate significant difference (P<0.05).
Fig 4The apoptotic index in SCNT reconstructed blastocysts derived from control or TUDCA-treated donor cells.
Apoptotic nuclei were stained as green by TUNEL assay, DNA was counterstained with DAPI to visualize as blue. Scale bar: 20 μm.
Fig 5Relative mRNA abundance of Ire1, Bip, Chop, Bax, Bcl-2, Hdac1 and Dnmt1 genes in SCNT reconstructed blastocysts derived from control or TUDCA-treated donor cells.
a,b: different letters indicate significant difference (P<0.05).